Addiction

Article	Citations
Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling	301
An Addiction series on regional perspectives on addiction‐related problems	287
Society for the Study of Addiction Annual Conference 2024	140
	122
	109
The use of financial incentives for smoking cessation in pregnant women: A parallel‐group randomised controlled trial protocol	106
Use of cessation products, e‐cigarettes and cigarette cessation outcomes among adults with substance use problems: Results from 2013–2021 (Waves 1–6) of the Population Assessment of Tobacco and Health	96
Structure and stability of internet gaming disorder from childhood to late adolescence: A 5‐wave birth cohort study	94
Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity	89
Will Australia's tightened prescription system reduce nicotine vaping among young people?	83
Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms	79
Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis	73
Response to Hall et al.: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness	73
Age, period and cohort effects of heavy episodic drinking by sex/gender and socioeconomic position in Canada, 2000–2021	71
Nicotine strength of e‐liquids used by adult vapers in Great Britain: A population survey 2016 to 2024	70
Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications	67
The Baltics: Benchmarking alcohol control reform for the European Union and surrounding countries	64
Significant changes in preference of illicit drug use in a population of Hanoi, Vietnam—A 6‐year wastewater study (2018–2023)	58
ABC‐training as a new intervention for hazardous alcohol drinking: Two proof‐of‐principle randomized pilot studies	53
	51
Rare but relevant series	48
Evaluating the optimal duration of medication treatment for opioid use disorder	46
Cost‐effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO‐HCV trial	44
Factors associated with the percentage of individuals who initiate and discontinue naltrexone as a relapse prevention pharmacotherapy in opioid use disorder: A systematic review, meta‐analysis and met	42
Estimating recent trends in alcohol sales in the United Kingdom from alcohol duty revenue	42

Austin Bradford Hill’s ‘Environment and disease: Association or causation’	41
Predictors of substance use during treatment for addiction: A network analysis of ecological momentary assessment data	41
Longitudinal associations between substance use problem severity and relative harm perceptions of e‐cigarettes compared with cigarettes: Results from the United States Population Assessment of Tobacco	40
Commentary on Stull et al.: Considering person‐specific heterogeneity when modeling time‐varying trends	39
Systematic review and meta‐analyses of cytisine to support tobacco cessation	38
Quantifying alcohol‐attributable disability‐adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data	37
Recent decline in Chinese alcohol production and consumption: Potential contributing factors and the role of globally recommended measures	37
Real‐world comparative effects of slow‐release oral morphine vs. methadone on healthcare use for opioid use disorder: A population‐based target trial emulation	37
National profile on substance use, substance use‐related problems and policy: The case of Chile	37
The prevalence of cannabidiol (CBD) use in North America and Europe: A meta‐analysis	36
Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial	36
Impulsivity behaviors and white matter mediate the relationship between genetic risk for cannabis use disorder and early cannabis use in adolescents	35
Non‐alcoholic beverage consumption among US adults who consume alcohol	35
Author Index	35
Risky alcohol consumption among women in Australia attending breast screening services: an exploratory cross‐sectional study	34
Commentary on Metcalfe et al.: ‘What works in AOD is when it feels like I am driving’ (Craig W, alcohol and drug peer worker)	33
	32
Commentary on Lannoy et al.: The continued value of within‐family designs in addiction and psychiatric research	32
Longitudinal trajectories of marijuana use in tobacco products among young adult Texas college students from 2015 to 2019	32
Clinical alcohol guidelines are welcome—but upstream action is paramount	31
Issue Information	30
	30
Issue Information	30
A return on investment analysis for the 2017 increase in alcohol excise taxation in Lithuania	29
How research and policy can shape driving under the influence of cannabis	28
New Books	28
Commentary on Amin‐Esmaeili et al .: Non‐abstinence outcomes in stimulant clinical trials—Why deny improvement?	28
Commentary on Luukkonen et al.: Policy possibilities for reducing public health harms related to pregnant people’s alcohol consumption	28
‘If you've ever experienced it, you'd feel differently’: Exploring willingness and skepticism toward using higher dose naloxone products among people who use drugs in Maryland, United States	28
Exploring the intersection of heavy alcohol use and masculine norms as risk factors for male‐to‐female intimate partner violence: Evidence from an Australian national survey	28
Perspectives on addiction‐related problems in India	28
	27
Changes in wastewater measures of alcohol consumption in Alice Springs, Australia, 1 year after the introduction of restrictions on alcohol sales	27
Unlocking ‘stuckness’ and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic‐assisted therapy for substance use and mental health problems	27
Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis	27
Neurophysiological error processing and addiction self‐awareness correlates of reduced insight in cannabis use disorder	27
Implications of the shift to DSM‐5 for alcohol use disorder prevalence estimates in the National Survey on Drug Use and Health	27
Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities	26
Genetic support of a causal relationship between cannabis use and educational attainment: a two‐sample Mendelian randomization study of European ancestry	26
On the need and contents of a specific addiction recovery research agenda	25
A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine	25
Personalizing smoking cessation pharmacotherapy using neuroaffective reactivity profiles: A randomized controlled trial	25
The association between family environment and food addiction in children and adolescents: A prospective cohort study	25
Commentary on Zacher et al .: How cocaine memories may drive craving and drug instrumentalization	25
Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study	25
Obstetric pain management for pregnant women with opioid use disorder: A qualitative and quantitative comparison of patient and provider perspectives (QUEST study)	25
Changes to our editorial team	24
Age–period–cohort analysis of past 12‐month cannabis use in Germany (1995–2021)	24
	24
Cannabis research in context: The case for measuring and embracing regional similarities and differences	24

Pain in people seeking and receiving opioid agonist treatment: A systematic review and meta‐analysis of prevalence and correlates	24
England's disposable vape ban: An inadequate solution to youth vaping with potential unintended consequences	24
Discrepancies between self‐reported alcohol use and breathalyzer results and factors associated with blood alcohol concentration positivity among road traffic injury patients in Cameroon	24
Evaluating the causal effect of tobacco smoking on white matter brain aging: a two‐sample Mendelian randomization analysis in UK Biobank	24
Identifying and describing trajectories of alcohol use frequency and binge drinking frequency among those aged 15–30 years in a national cohort of US adolescents: A group‐based trajectory modeling app	24
Expanding the boundaries of harm reduction: Why anabolic‐androgenic steroid users require a paradigm shift	24
Nicotine pouch use by sex, school type and tobacco product use among Finnish adolescents during the 2023 change in regulatory scheme with deregulated sales	23
Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports	23
Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta‐analysis	23
‘I'd rather have worse gums than worse lungs’: Young people's views of nicotine pouches in the UK	23
Alcohol‐free and low‐alcohol beverage consumption and concurrent and subsequent alcohol outcomes among young adults	23
Sludge, dark patterns and dark nudges: A taxonomy of online gambling platforms' deceptive design features	23
	22
Issue Information	22
Evaluating the impact of vaping facts films on vaping harm perceptions among young adults in the UK: A randomized on‐line experiment	22
Issue Information	22
Commentary on Schmidt et al.: Informed patient preference and prioritizing access to medications for opioid use disorder for pregnant individuals	22
Issue Information	22
Issue Information	22
The interaction of e‐cigarette use and mental health symptoms on risk of cigarette smoking initiation among young adults in the United States	21
Seeing through a glass darkly	21
Prosecuting Poverty, Criminalizing Care. By WendyBach, Cambridge, UK: Cambridge University Press. 2022. ISBN: 9781108465533	21
Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting‐related bacterial and fungal infections	21
Development of a novel risk score reflecting the relative harm potential of synthetic cannabinoids based on prevalence estimates, well‐documented intoxication cases and basic pharmacological data	21
	21
Social genetic effects for drug use disorder among spouses	21
Commentary on Petrilliet al.: Assessing cannabis use in real‐world settings ‐ advances using standard THC units	21
Systematic review of symptom‐level networks of alcohol use disorder	21
New perspectives on how to formulate alcohol drinking guidelines: Response to commentaries	21
Drugs, Identity and Stigma. By MichelleAddison, WilliamMcGovern & RuthMcGovern. Chan, Switzerland: Palgrave Macmillan, 2022. ISBN: 9783030982867	21
#NoIDVape: A content analysis of illicit vape messaging in young people's information sources	20
Cannabis vaping and mental health: The association of Δ‐9‐tetrahydrocannabinol and cannabidiol with anxiety and depressive symptoms—Findings from the United States National Youth Tobacco Survey (2021–	20
Deficits in general and smoking‐specific response inhibition in the Go/No‐Go task in individuals who smoke: A cross‐sectional analysis	20
Health and economic impact of universal screening and management of alcohol use disorders in India: An economic modelling study	20
Changing patterns of nicotine product use and nicotine dependence among United States high‐school students: The National Youth Tobacco Survey, 2014–2023	20
‘It's not what you'd term normal smoking’: a qualitative exploration of language used to describe heated tobacco product use and associated user identity	20
Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA	20
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review	20
Disentangling the contributions of alcohol use disorder and alcohol‐related liver disease towards dementia: A population‐based cohort study	19
Addiction Lives: Sir Ian Gilmore	19
Commentary on Jones et al.: We must consider emergency medical services data an opportunity for a view into a community	19
Prognostic significance of prior alcohol use disorder in patients with presumed metabolic dysfunction‐associated steatotic liver disease: A large multi‐center cohort study	19
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries	19
Addiction Lives: Robin Davidson	19
Clinical factors linked to xylazine exposure in emergency department patients with illicit opioid overdose	19
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era	19
Issue Information	19
New Books	19
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers	18
How to interpret studies on the impact of legalizing cannabis	18
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type	18
Multivariable machine learning prediction of risky alcohol use in contemporary youth	18
Disparities in the receipt of alcohol brief intervention: The intersectionality of sex, age, and race/ethnicity	18
Systematic review and meta‐analysis investigating nicotine, cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy	18
Differences in benefits of office based opioid treatment: Secondary analyses across sub‐groups in the PROUD randomized controlled implementation trial	18
Should contingency management protocols and dissemination practices be modified to accommodate rising stimulant use and harm reduction frameworks?	18
Do internalising or externalising behaviours in adolescence mediate the child maltreatment‐alcohol substance use relationship?	18
Daily associations between sleep and alcohol use among veterans: Acute and cumulative effects	18
Issue Information	18
Rare but relevant: Hydrocarbons and sudden sniffing syndrome	17
Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias	17
Offering e‐cigarettes for smoking cessation and reduction in people with mental illness (ESCAPE): Protocol for a randomized controlled trial	17
Could alcohol‐free and low‐alcohol beverages be used to extinguish alcohol cravings?	17
How people decide to consume (more) alcohol when feeling stressed	17
Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial	17
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID‐19 pandemic: An interrupted time‐series analysis in	17
Enhancing recovery science: From theory to life stage and context, to subpopulations and new paradigmatic thinking	17
Navigating pregnancy and addiction recovery: Patient perspectives on perinatal care interventions for women with opioid use disorder in Kentucky, USA	17
Commentary on Craft et al.: Drug contaminants and substitutions in illicit vapes represent a major health risk	17
A cost–benefit analysis of the implementation and scale‐up of harm reduction interventions in the Australian Capital Territory	17
Commentary on Nieto et al .: The heterogeneity of drug craving and considerations as a treatment endpoint	16
Alcohol drinking, DNA methylation and psychiatric disorders: A multi‐omics Mendelian randomization study to investigate causal pathways	16
Rapid growth in disposable e‐cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross‐sectional survey	16
	16
Glucagon‐like peptide‐1 receptor agonists in alcohol use disorder: Multi‐system effects, early clinical promise and uncertain long‐term use	16
Association between state‐level kratom regulations and poison center‐reported severe medical outcomes and healthcare use: A United States national analysis	16
Commentary on Zhu et al .: Nitazenes—Tracking a moving target from linked United States databases	16
A systematic review and meta‐analysis of self‐reported exposure to cannabis advertising and its association with cannabis use and intentions	16
Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study	16
The efficacy of an internet‐based cognitive behavioral program added to treatment‐as‐usual for alcohol‐dependent patients in primary care: a randomized controlled trial	16

The price of a cigarette: 20 minutes of life?	16
Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders	16
From emergence to replacement: The evolution of 3‐methylmethcathinone (3‐MMC) and its substitutes in the Dutch drug market (2012–2024)	16
New Books	16
Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol‐free and low‐alcohol products in higher risk groups	16
Evaluating the impact of minimum unit pricing for alcohol on road traffic accidents in Scotland after 20 months: An interrupted time series study	16
Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022	15
Issue Information	15
Using ecological momentary assessment to quantify Δ‐9‐tetrahydrocannabinol and cannabidiol use across different forms of cannabis: Feasibility in a sample of Canadian young adults reporting frequent c	15
Commentary on Jackson et al.: The role of regional tobacco control in centralised nations	15
Commentary on Mereish et al .: Supporting sexually diverse youth requires a full spectrum understanding of substance use	15
Mainstreaming smoking cessation brief advice in health systems using the United Nations human rights system	15
Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000–2025	15
Issue Information	15
	15
Commentary on Sun and Tang: Measurement assessment and validity in problematic smartphone use	15
Issue Information	15
Stakeholders cannot simply wait for the gambling evidence‐base to develop: We must all help to build it	14
Associations between modes of cannabis use and cannabis use disorder: Evidence from the 2022 to 2023 United States National Survey on Drug Use and Health	14
Associations between the national ‘Swap to Stop’ programme offering free vapes for smoking cessation and quit attempts in England: Results from a population‐based survey	14
Cannabis use and sleep problems among young adults by mental health status: A prospective cohort study	14
Better data access can lead to better collaborative conclusions: Results of a discussion with Heirene	14
Response to Crockford et al .: Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented diff	14
Yes, nitrous oxide addiction undeniably exists!	14
Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada	14
Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews	14
Harmful compared to what? The problem of gaming and ambiguous causal questions	14
Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug‐testing and law enforcement	14
Cost–utility analysis of provision of e‐cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial	14
Issue Information	13
Issue Information	13
Commentary on Hyland et al.: Digital treatment for alcohol use disorders ‐ challenges and opportunities	13
Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target	13
The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia	13
The association between state cannabis policies and cannabis use among adults and youth, United States, 2002–2019	13
Addiction Lives: Viv Evans	13
Changes to our Editorial Team	13
Deaths of despair	13
Understanding perceived addiction to and addictiveness of electronic cigarettes among electronic cigarette users: a cross‐sectional analysis of the International Tobacco Control Smoking and Vaping (IT	13
RETRACTION: Proportions and Correlates of High‐Risk Cannabis Use in Australia—A Cross‐Sectional Analysis of the 2022–2023 National Drug Strategy Household Survey	13
Referees	13
Issue Information	13
Drunken snakes and sober owls: ancient authors on the relationship between animals and wine	13
Commentary on Manthey et al .: No more missed opportunities—We need to address the absence of robust and comprehensive evaluations about the real‐world i	13
The evolution of Australian cannabis policies, 1967 to 2024	13
Atipamezole merits investigation for use in human α‐2 agonist toxicity	12
Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies	12
Will social media bans reduce the amount of substance use‐related content to which young people are exposed?	12
Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use	12
Alcohol use disorder criteria exhibit different comorbidity patterns	12
Changing trends in drug overdose mortality in Spain, 2001–2022	12
Quantification of racial and ethnic disparities in alcohol‐related problems in light of different methodological approaches	12
Effect of perioperative high‐dose transdermal nicotine patch on pain sensitivity among male abstinent tobacco smokers undergoing abdominal surgery: A randomized controlled pilot study	12
On the duration of cannabis effects and the presence of THC in the body	12
Clinical management of psychostimulant withdrawal: review of the evidence	12
Cannabis policy bundles and traffic fatalities in the American States over time	12
	12
Evaluation of statewide restrictions on e‐cigarette nicotine strength—United States, 2017–2022	12
Is methamphetamine blood concentration in emergency department patients associated with the clinical picture?	12
Post‐legalization shifts in cannabis use among young adults in Georgia—A nationally representative study	12
Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA	12
Understanding successful policy innovation: The case of Portuguese drug policy	11
How much does the absence of the ‘hidden population’ from United Kingdom household surveys underestimate smoking prevalence?	11
How effective are remote and/or digital interventions as part of alcohol and drug treatment and recovery support? A systematic review and meta‐analysis	11
Packaging of disposable vaping products and e‐liquids in England, Canada and the United States: A content analysis	11
Red Box, Green Box: Psychometric evaluation of a self‐report behavioral frequency measurement approach for behavioral addictions research	11
Why it is important to conduct gambling research that is fair and free from conflicts of interest	11
Issue Information	11
Prolonged diacetylmorphine take‐home during the COVID‐19 pandemic—Results of a retrospective cohort study	11
A systematic review and meta‐analysis of factors associated with adolescent substance use in Africa, 2000 to 2020	11
Effect of 3 months and 12 months of financial incentives on 12‐month postpartum smoking cessation maintenance: A randomized controlled trial	11
Classifying national drinking patterns in Europe between 2000 and 2019: A clustering approach using comparable exposure data	11
Systematic review of patient‐reported outcome measures for opioid use disorder recovery	11
Extended‐release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review	11
Predictors of alcohol and other drug treatment completion among young people accessing residential and community‐based treatment: A retrospective analysis of routinely collected service data	11
Within‐person associations of escalated electronic nicotine delivery systems use with cigarette, alcohol, marijuana and drug use behaviors among US young adults	11
Comparison of strength and adulteration between illicit drugs obtained from cryptomarkets versus off‐line	11
Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta‐analysis	11
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence	11
Has Australia lost control of its tobacco and nicotine markets?	11
Cannabis and sport: A World Anti‐Doping perspective	11
Issue Information	11
Electronic cigarettes and subsequent use of cigarettes in young people: An evidence and gap map	10
Issue Information	10
Non‐alcoholic beer labeling in the United States	10
Changes to our editorial team	10
Socio‐economic inequalities in smoking and drinking in adolescence: Assessment of social network dynamics	10
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study	10
The environmental impact of tobacco products: Time to increase awareness and action	10
Is toke cheap? Correspondence between cannabis demand and purchase in the laboratory	10
Co‐action and changes in alcohol use during a smoking cessation attempt	10
GLP‐1R agonist medications for addiction treatment	10
Stimulant‐induced psychosis requires the same clinical priority as other psychotic disorders	10
Will Australia's tightened prescription system reduce nicotine vaping among young people?	10
	10